Empagliflozin shows efficacy when added to metformin and sulfonylurea

08/27/2013 | MedPage Today (free registration)

Type 2 diabetes patients who took daily doses of empagliflozin as an add-on to metformin/sulfonylurea treatment attained greater reductions in A1C at six months than those in the placebo group, according to a study in Diabetes Care. Greater weight loss and improved systolic blood pressure were also seen in the empagliflozin arm compared with the control group, researchers noted.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID